116
Views
3
CrossRef citations to date
0
Altmetric
Connective tissue diseases and related disorders

Predictive value of magnetic resonance imaging for multifocal osteonecrosis screening associated with glucocorticoid therapy

, , , , , , , , , & show all
Pages 586-591 | Received 24 Jan 2019, Accepted 20 May 2019, Published online: 31 Jul 2019

References

  • Shigemura T, Nakamura J, Kishida S, Harada Y, Ohtori S, Kamikawa K, et al. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. Rheumatology (Oxford). 2011;50(11):2023–8.
  • Collaborative Osteonecrosis Group. Symptomatic multifocal osteonecrosis. A multicenter study. Clin Orthop Relat Res. 1999;369:312–26.
  • LaPorte DM, Mont MA, Mohan V, Jones LC, Hungerford DS. Multifocal osteonecrosis. J Rheumatol. 1998;25(10):1968–74.
  • Zhang NF, Li ZR, Wei HY, Liu ZH, Hernigou P. Steroid-induced osteonecrosis: the number of lesions is related to the dosage. J Bone Joint Surg Br. 2008;90(9):1239–43.
  • Drescher W, Schneider T, Becker C, Hobolth J, Rüther W, Hansen ES, et al. Selective reduction of bone blood flow by short-term treatment with 60 high-dose methylprednisolone. An experimental study in pigs. J Bone Joint Surg Br. 2001;83(2):274–7.
  • Oinuma K, Harada Y, Nawata Y, Takabayashi K, Abe I, Kamikawa K, et al. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis. 2001;60(12):1145–8.
  • Lopez-Ben R, Mikuls TR, Moore DS, Julian BA, Bernreuter WK, Elkins M, et al. Incidence of hip osteonecrosis among renal transplantation recipients: a prospective study. Clin Radiol. 2004;59(5):431–8.
  • Takao M, Sakai T, Nishii T, Yoshikawa H, Takahara S, Sugano N, et al. Incidence and predictors of osteonecrosis among cyclosporin- or tacrolimus-treated renal allograft recipients. Rheumatol Int. 2011;31(2):165–70.
  • Nawata K, Nakamura J, Ikeda K, Furuta S, Nakajima H, Ohtori S, et al. Transitional changes in the incidence of osteonecrosis in systemic lupus erythematosus patients: focus on immunosuppressant agents and glucocorticoids. Rheumatology (Oxford). 2018;57(5):844–9.
  • Sakamoto M, Shimizu K, Iida S, Akita T, Moriya H, Nawata Y. Osteonecrosis of the femoral head: a prospective study with MRI. J Bone Joint Surg Br. 1997;79(2):213–9.
  • Iida S, Harada Y, Shimizu K, Sakamoto M, Ikenoue S, Akita T, et al. Correlation between bone marrow edema and collapse of the femoral head in steroid-induced osteonecrosis. AJR Am J Roentgenol. 2000;174(3):735–43.
  • Shimizu K, Moriya H, Akita T, Sakamoto M, Suguro T. Prediction of collapse with magnetic resonance imaging of avascular necrosis of the femoral head. J Bone Joint Surg Am. 1994;76(2):215–23.
  • Ohzono K, Saito M, Takaoka K, ono K, Saito S, Nishina T, let al. Natural history of nontraumatic avascular necrosis of the femoral head. J Bone Joint Surg Br. 1991;73:68–72.
  • Kobayashi S, Kubo T, Iwamoto Y, Fukushima W, Sugano N. Nationwide multicenter follow-up cohort study of hip arthroplasties performed for osteonecrosis of the femoral head. Int Orthop (SICOT). 2018;42(7):1661–8.
  • Sugano N, Atsumi T, Ohzono K, Kubo T, Hotokebuchi T, Takaoka K. The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head. J Orthop Sci. 2002;7(5):601–5.
  • Shigemura T, Nakamura J, Shimizu K, Iida S, Oinuma K, Kishida S, et al. Articular collapse and surgical frequency in corticosteroid-associated osteonecrosis of the femoral head and the knee: an MRI-based prospective study. Eur Orthop Traumatol. 2014;5(2):153–60.
  • Tomaru Y, Yoshioka T, Sugaya H, Aoto K, Wada H, Akaogi H, et al. Hip preserving surgery with concentrated autologous bone marrow aspirate transplantation for the treatment of asymptomatic osteonecrosis of the femoral head: retrospective review of clinical and radiological outcomes at 6 years postoperatively. BMC Musculoskelet Disord. 2017;18:292.
  • Kuroda Y, Asada R, So K, Yonezawa A, Nankaku M, Mukai K, et al. A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head. Int Orthop (SICOT). 2016;40(8):1747–54.
  • Felson DT, Anderson JJ. Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet. 1987;1:902–6.
  • Takao M, Sugano N, Nishii T, Miki H, Yoshikawa H. Spontaneous regression of steroid-related osteonecrosis of the knee. Clin Orthop Relat Res. 2006;452:210–5.
  • Sakai T, Sugano N, Ohzono K, Matsui M, Hiroshima K, Ochi T. MRI evaluation of steroid- or alcohol-related osteonecrosis of the femoral condyle. Acta Orthop Scand. 1998;69(6):598–602.
  • Iida S, Harada Y, Ikenoue S, Moriya H. Measurement of bone marrow blood volume in the knee by positron emission tomography. J Orthop Sci. 1999;4(3):216–22.
  • Ahlbäck S, Bauer GC, Bohne WH. Spontaneous osteonecrosis of the knee. Arthritis Rheum. 1968;11(6):705–33.
  • Yamamoto T, Bullough PG. Spontaneous osteonecrosis of the knee: the results of subchondral insufficiency fractures. J Bone Joint Surg Am. 2000;82(6):858–66.
  • Shigemura T, Nakamura J, Kishida S, Harada Y, Takeshita M, Takazawa M, et al. The incidence of alcohol-associated osteonecrosis of the knee is lower than the incidence of steroid-associated osteonecrosis of the knee: an MRI study. Rheumatology (Oxford). 2012;51(4):701–6.
  • Nakamura J, Ohtori S, Watanabe A, Nakagawa K, Inoue G, Kishida S, et al. Recovery of the blood flow around the femoral head during early corticosteroid therapy: dynamic magnetic resonance imaging in systemic lupus erythematosus patients. Lupus. 2012;21(3):264–70.
  • Shigemura T, Nakamura J, Harada Y, Sakamoto M, Takahashi K, Kishida S. Incidence of steroid-associated osteonecrosis of the talus: a prospective MRI study. Eur Orthop Traumatol. 2013;4(4):237–40.
  • Sakai T, Sugano N, Nishii T, Hananouchi T, Yoshikawa H. Extent of osteonecrosis on MRI predicts humeral head collapse. Clin Orthop Relat Res. 2008;466(5):1074–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.